Postmarketing migraine survey of frovatriptan: effectiveness and tolerability vs previous triptans, NSAIDs or a combination

References

• Harpole LH, Samsa GP, Matchar DB, et al. Burden of illness and satisfaction with care among patients with headache seen in a primary care setting. Headache 2005;45:1048-55
   PubMed Web of Science ®Google Scholar
• Malik SN, Hopkins M, Young WB, et al. Acute migraine treatment: patterns of use and satisfaction in a clinical population. Headache 2006;46:773-80
   PubMed Web of Science ®Google Scholar
• Mathew NT, Kailasam J, Gentry P, et al. Treatment of nonresponders to oral sumatriptan with zolmitriptan and rizatriptan: a comparative open trial. Headache 2000;40:464-5
   PubMed Web of Science ®Google Scholar
• Powers C, Szeto S, Pangtay D et al. Evaluation of migraineurs’ preferences for naratriptan over conventional first-line agents. Arch Fam Med 2000;9:753-8
   PubMedGoogle Scholar
• Cady R, Martin V, Mauskop A et al. Efficacy of rizatriptan 10 mg administered early in a migraine attack. Headache 2006;46:914-24
   PubMed Web of Science ®Google Scholar
• Cady R, Elkind A, Goldstein J, et al. Randomized, placebo-controlled comparison of early use of frovatriptan in a migraine attack versus dosing after the headache has become moderate or severe. Curr Med Res Opin 2004;20:1465-72
   PubMed Web of Science ®Google Scholar
• Mathew NT. Early intervention with almotriptan improves sustained pain-free response in acute migraine. Headache 2003;43:1075-9
   PubMed Web of Science ®Google Scholar
• Mathew NT, Kailasam J, Meadors L. Early treatment of migraine with rizatriptan: a placebo-controlled study. Headache 2004;44:669-73
   PubMed Web of Science ®Google Scholar
• Landy S, Savani N, Shackelford S et al. Efficacy and tolerability of sumatriptan tablets administered during the mild-pain phase of menstrually associated migraine. Int J Clin Pract 2004;58:913-19
   PubMed Web of Science ®Google Scholar
• Silberstein S. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee for the American Academy of Neurology. Neurology 2000;55:754-62
   PubMed Web of Science ®Google Scholar
• Geraud G, Lanteri-Minet M, Lucas C, et al. French guidelines for the diagnosis and management of migraine in adults and children. Clin Ther 2004;26:1305-18
   PubMed Web of Science ®Google Scholar
• Smith TR, Banks JW, Nicholson RA. ‘Is a triptan the first medication you take?’: how order of use differentiates migraine sufferers’ triptan adherence and quality of life. Headache 2007;47:755
   Web of Science ®Google Scholar
• Garcia-Ramos G, MacGregor EA, Hilliard B et al. Comparative efficacy of eletriptan vs. naratriptan in the acute treatment of migraine. Cephalalgia 2003;23:869-76
   PubMed Web of Science ®Google Scholar
• Allais G, Acuto G, Cabarrocas X et al. Efficacy and tolerability of almotriptan versus zolmitriptan for the acute treatment of menstrual migraine. Neurol Sci 2006;27:S193-7
   PubMed Web of Science ®Google Scholar
• Nett R, Landy S, Shackelford S et al. Pain-free efficacy after treatment with sumatriptan in the mild pain phase of menstrually associated migraine. Obstet Gynecol 2003;102:835-42
   PubMed Web of Science ®Google Scholar
• Ferrari MD, Roon KI, Lipton RB, et al. Oral triptans (serotonin 5-HT1B/1D agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet 2001;358:1668-75
   PubMed Web of Science ®Google Scholar
• Dahlof CG. Infrequent or non-response to oral sumatriptan does not predict response to other triptans – review of four trials. Cephalalgia 2006;26:98-106
   PubMed Web of Science ®Google Scholar
• Diener HC, Gendolla A, Gebert I, et al. Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial. Headache 2005;45:874-82
   PubMed Web of Science ®Google Scholar
• Farkkila M, Olesen J, Dahlof C et al. Eletriptan for the treatment of migraine in patients with previous poor response or tolerance to oral sumatriptan. Cephalalgia 2003;23:463-71
   PubMed Web of Science ®Google Scholar
• Krymchantowski AV. Acute treatment of migraine. Breaking the paradigm of monotherapy. BMC Neurol 2004;4:4
   PubMed Web of Science ®Google Scholar
• Krymchantowski AV, Bigal ME. Polytherapy in the preventive and acute treatment of migraine: fundamentals for changing the approach. Expert Rev Neurother 2006;6:283-9
   PubMedGoogle Scholar
• Krymchantowski AV, Adriano M, Fernandes D. Tolfenamic acid decreases migraine recurrence when used with sumatriptan. Cephalalgia 1999;19:186-7
   PubMed Web of Science ®Google Scholar
• Krymchantowski AV. Naproxen sodium decreases migraine recurrence when administered with sumatriptan. Arq Neuropsiquiatr 2000;58:428-30
   PubMed Web of Science ®Google Scholar
• Loder E. Fixed drug combinations for the acute treatment of migraine: place in therapy. CNS Drugs 2005;19:769-84
   PubMed Web of Science ®Google Scholar
• Brandes JL, Kudrow D, Stark SR et al. Sumatriptan–naproxen for acute treatment of migraine: a randomized trial. JAMA 2007;297:1443-54
   PubMed Web of Science ®Google Scholar
• Pfaffenrath V, Spierings EL. [Treatment of acute migraine attacks: effective and economic alternative.] Nervenheilkunde 2004;23:545-8
   Web of Science ®Google Scholar
• Diener HC, Gendolla A. Part IV: effects of zolmitriptan orally disintegrating tablet on migraine symptoms and ability to perform normal activities: a post-marketing surveillance study in Germany. Curr Med Res Opin 2005;21(Suppl. 3):S18-24
   PubMedGoogle Scholar
• Zimmermann T, Dietrich H, Wisser KH, et al. The efficacy and tolerability of Valette: a postmarketing surveillance study. Eur J Contracept Reprod Health Care 1999;4:155-64
   PubMed Web of Science ®Google Scholar
• Hajak G, Bandelow B. Safety and tolerance of zolpidem in the treatment of disturbed sleep: a post-marketing surveillance of 16944 cases. Int Clin Psychopharmacol 1998;13:157-67
   PubMed Web of Science ®Google Scholar
• Bigal M, Rapoport A, Aurora S et al. Satisfaction with current migraine therapy: experience from 3 centers in US and Sweden. Headache 2007;47:475-9
   PubMed Web of Science ®Google Scholar
• Ryan R, Geraud G, Goldstein J et al. Clinical efficacy of frovatriptan: placebo-controlled studies. Headache 2002;42(Suppl. 2):S84-92
   PubMed Web of Science ®Google Scholar
• Geraud G, Keywood C, Senard JM. Migraine headache recurrence: relationship to clinical, pharmacological, and pharmacokinetic properties of triptans. Headache 2003;43:376-88
   PubMed Web of Science ®Google Scholar
• Chia YC, Lim SH, Wang SJ et al. Efficacy of eletriptan in migraineurs with persistent poor response to nonsteroidal anti-inflammatory drugs. Headache 2003;43:984-90
   PubMed Web of Science ®Google Scholar
• Stronks DL, Tulen JH, Bussmann HB et al. Effects of naratriptan versus naproxen on daily functioning in the acute treatment of migraine: a randomized, double-blind, double-dummy, crossover study. Headache 2003;43:845-52
   PubMed Web of Science ®Google Scholar
• Eich E, Reeves JL, Jaeger B, et al. Memory for pain: relation between past and present pain intensity. Pain 1985;23:375-80
   PubMed Web of Science ®Google Scholar
• van den Brink M, Bandell-Hoekstra EN, Abu-Saad HH. The occurrence of recall bias in pediatric headache: a comparison of questionnaire and diary data. Headache 2001;41:11-20
   PubMed Web of Science ®Google Scholar
• Stark S, Spierings EL, McNeal S et al. Naratriptan efficacy in migraineurs who respond poorly to oral sumatriptan. Headache 2000;40:513-20
   PubMed Web of Science ®Google Scholar
• Tobin J, Shaw R, Pawsey S et al. Characteristics of patients with inadequate responses to acute triptan treatment for menstrual migraine. Headache 2007;47:786
   Web of Science ®Google Scholar
• Jhee SS, Shiovitz T, Crawford AW, et al. Pharmacokinetics and pharmacodynamics of the triptan antimigraine agents: a comparative review. Clin Pharmacokinet 2001;40:189-205
   PubMed Web of Science ®Google Scholar
• Frova® tablets (frovatriptan succinate). Full Prescribing Information, Endo Pharmaceuticals Inc., Chadds Ford, PA, 2007
   Google Scholar
• Geraud G, Spierings EL, Keywood C. Tolerability and safety of frovatriptan with short- and long-term use for treatment of migraine and in comparison with sumatriptan. Headache 2002;42(Suppl. 2):S93-9
   PubMedGoogle Scholar